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 25%69 67 25 ≥%35 34
 75< 5025
 10003
3 25 :مفتاح الكلمات
aBStract: Objectives: The objective of this study was to determine the vitamin D status of pregnant Omanis by 
measurement of their circulating 25 hydroxy vitamin D levels. Methods: Blood samples were obtained from a cohort 
of 103 consecutive healthy pregnant Omanis at the Armed Forces Hospital, Muscat, on their first antenatal visit. 
The study took place in May, June and July 2010. Results: Vitamin D deficiency was present in 34 (33%) of patients 
(25OHD3 <25 nmol/L), ‘at risk’ levels were found in 67 (65%) patients (25OHD3 25–50 nmol/L); two patients (1.9%) 
had values between 50 and 75 nmol/L, and no patients in the optimal range >75 nmol/L. Conclusion: If confirmed, 
these findings indicate the need for vitamin D replacement during pregnancy and lactation. Although not evidence 
based we recommend at least 1000 IU of cholecalciferol, (vitamin D3) daily.
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ADVanceS in KnoWleDGe
This article is the first to draw attention to the possibility of widespread vitamin D deficiency among pregnant women in Oman. 
Application to Patient Care
Until more is known about the vitamin D status in Omanis, we recommend that all pregnant women and lactating mothers should receive
vitamin D supplements with at least 1000 IU vitamin D3 daily.
Deficiency of vitamin D is common worldwide1 including the Gulf states.2,3 The latter is surprising as sunlight is 
abundant in the Middle East. More than 90% of our 
vitamin D is provided by sunlight4 and it is therefore 
obvious that those persons affected in Arabian 
countries have little sunlight exposure and a diet 
deficient in vitamin D. 
The role of vitamin D in normal physiology 
is complex and wide ranging. It has important 
immune modulating effects protecting against 
infection,4,5,6 autoimmune disorders7 and certain 
cancers, in addition to its well documented effects 
on the prevention of osteoporosis, fractures, falls in 
the elderly4,5 and impaired cognitive function.8 
As we continually see patients with vitamin D 
deficiency in our clinics, it became important to 
establish whether or not vitamin stores (25OHD) 
are normal in a healthy Omani population. For this 
reason, we chose patients in their first and second 
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trimester of pregnancy as pregnancy and lactation 
are associated with profound alterations in calcium 
absorption and skeletal remodelling necessitating 
increased utilisation of vitamin D. Our findings are 
reported below.
Methods
Blood samples were obtained from a cohort of 103 
consecutive healthy Omani patients at their first 
antenatal visit, usually in the first, but sometimes 
the second trimester. They were then assayed for 
serum calcium (Ca), phosphate (Phos), and serum 
alkaline phosphatase (ALP), which were measured 
by spectrophotometry, (COBAS Integra 800, Roche 
Diagnostics, Indianapolis, USA) on the same day. 
Serum samples for parathyroid hormone (PTH)
were measured by immunochemiluminesence 
(Access 2, Beckman Coulter, Inc., CA, USA), and 
25(OH)D3 by the LB211 gamma counter (Berthold 
GmBH & Co. KG, Bad Wilbad, Germany), having 
been centrifuged and deep frozen at –40º C . PTH 
and 25(OH)D3 were then measured on the same day 
at the end of the study.
Statistical analysis was performed to determine 
the relationship between the level of serum Ca, 
Phos, ALP and PTH versus the level of serum 
25(OH)D. We used a correlation test to calculate the 
significance of these relationships. As this showed 
no significant linear correlation, a polynomial trend 
curve was employed. The calculations were made 
for all groups of patients.
Fully informed consent was obtained from each 
patient to extract the blood needed for the above 
procedures in addition to that required for routine 
antenatal screening. The study was approved by the 
Armed Forces Hospital authorities.
Results
Serum 25OHD3 levels were deficient (<25 nmol/L) 
in 34 patients, between 25 and 50 nmol/L in 67 
patients (at risk) and two patients had values 
between 50 and 75 nmol/L. There was no 
significant linear correlation between 25(OH)
D3 and serum Ca, Phos or ALP levels or parity. 
However, a significant relationship between 
PTH and 25(OH)D3 was observed which differed 
between the ‘deficient’ and the ‘at risk’ groups. This 
was confirmed using a polynomial curve, which had 
a significant correlation value of 0.55 [Figure 1].
Discussion
This is the first study to report vitamin D status 
in normal pregnant Omanis. The results are 
alarming: 34% of these apparently healthy women 
were vitamin D deficient and a further 64% ‘at risk’ 
at a time when there is a critical need for calcium 
metabolism to be normal. A pregnant woman must 
provide 25 to 30 gm of calcium to support the 
developing foetal skeleton. Much of this demand 
Figure 1: Relationship between PTH (normal range 1.6–9.3 pmol/L) and 25(OH)D3 levels. There was no linear correlation 
between PTH and 25OHD3 levels, but using a polynomial curve, the correlation coefficient was significant at 0.55.
Legend: PTH = parathyroid hormone; 25(OH)D3 = vitamin D3.
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occurs in the third trimester when the foetal 
skeleton undergoes mineralisation. This demand 
is compensated for by an increased absorption of 
calcium from the gut induced by rising levels of 
PTH and the active metabolite of vitamin D, 1,25 
dihydroxy vitamin D (1,25(OH)2D).9  At this point 
25(OH)D will be utilised to make more 1,25(OH)2D 
and those patients with low stores will be at 
considerable risk for the development of vitamin D 
deficiency and osteoporosis in old age.10
To compound this problem, many Omani 
women have 6 or more children and breast feed for 
up to 2 years. During lactation, hyperabsorption 
of calcium does not occur and remineralisation 
of the maternal skeleton only starts after weaning 
when PTH, and 1,25(OH)2D levels rise, calcium 
absorption increases and urinary calcium levels fall, 
a process that may persist for months.11 Obviously, 
adequate stores of 25(OH)D are vital during this 
period, otherwise skeleton remineralisation will 
be seriously impaired and possibly result in the 
development of osteoporosis in old age.4,5
Interestingly, none of the patients in the 
25(OH)D3 deficiency group were symptomatic 
and serum PTH and ALP levels were still within 
the normal range. However there was a significant 
increase of the percentage rise in PTH in the face 
of a declining 25(OH)D level suggesting the early 
stages of a biological response to vitamin D 
deficiency in the “at risk” group. In the deficiency 
group the reverse response was seen. Our 25(OH)
D3 immunoassay results have been carefully 
checked and are correct. It is possible therefore 
that an overt rise of PTH and ALP levels has been 
suppressed by an oral intake of calcium in excess 
of 1 gm daily as this will delay the development of 
secondary hyperparathyroidism.12,13 Other factors 
such as body mass index may also be relevant14 but 
this was not examined here.
In addition to its musculo-skeletal actions, 
vitamin D deficiency is reportedly associated with 
the development of certain cancers, the metabolic 
syndromes and infections, as well as type 1 and 
type 2 diabetes,4,5 disorders which are common in 
Oman. 
Our results confirm that vitamin D3 stores are 
low even in Omanis of reproductive age. These 
findings are similar to those reported in Saudi 
Arabians more than 25 years ago2 and more 
recently in the UAE and Qatar.3,12 It therefore seems 
sensible to advocate vitamin D supplementation 
for all pregnant women in the Middle East. 
At the present time, there are no clear cut 
recommendations as to the dose, but we 
recommend at least 1000 IU of vitamin D3 a day 
which should be continued throughout lactation. 
Until more is known about the daily calcium intake 
of Omanis, it would be prudent to advocate calcium 
supplementation as well.15
Conclusion
This study shows that vitamin D3 scores are low in 
pregnant Omanis. Further studies are required to 
confirm these findings. Until then, we recommend 
supplementation with vitamin D3 (cholecalciferol) 
for all pregnant and lactating mothers.
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